Estimating Long-Term Survival of Adults with Philadelphia Chromosome-Negative Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia Treated with Blinatumomab Using Historical Data

INTRODUCTION: Blinatumomab is a bispecific T cell-engaging antibody construct indicated for adult patients with relapsed/refractory (R/R) Ph(−) B-precursor acute lymphoblastic leukemia (ALL), an aggressive disease with poor prognosis. A phase 2 single-arm clinical study showed that 43% of patients a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Adv Ther
Prif Awduron: Barlev, Arie, Lin, Vincent W., Katz, Aaron, Hu, Kuolung, Cong, Ze, Barber, Beth
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Healthcare 2016
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216100/
https://ncbi.nlm.nih.gov/pubmed/27873237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-016-0447-x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg